Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Methionine metabolism pathway enzymes" refers collectively to a set of **enzymes that catalyze the synthesis, utilization, recycling, and degradation of the essential amino acid methionine**. These include but are not limited to: **Key enzymes** in this network include: * **Methionine adenosyltransferase:** Converts methionine into S-Adenosylmethionine (SAM), a universal methyl donor critical for DNA/RNA/protein/lipid methylation reactions[1][2]. * **Methionine synthase:** Catalyzes the remethylation of homocysteine back to methionine using vitamin B12 as a cofactor; links folate and one-carbon cycles[1][2]. * **Betaïne-homocysteïne methyltransferase:** Alternative route for remethylating homocysteïne using betaine as a donor—predominantly active in liver/kidney[2]. * **S-Adenosylhomocysteinase:** Hydrolyzes SAH into adenosyne and homocycteïne; prevents feedback inhibition on other methyltransferases[2]. * **Cystathione β-synthase & cystathione γ-synthase/β–lyase:** Divert excess homocycteïne into transsulfuration pathway for cysteine/glutathione production—important for antioxidant defense and sulfur homeostasis[3][5]. These enzymes collectively regulate cellular pools of SAM/methioinine/homocycteïne/cystéíne. Their activity is tightly controlled by nutritional status (folate/B12/betaîne), feedback from metabolites like SAM/SAH/homocycteïne itself, transcriptional regulation according to cell growth needs or stress responses—and their dysfunction is implicated in cancer progression via altered epigenetic marks/methyl group supply; cardiovascular/neurodegenerative diseases via hyperhomocycteïnemia; inherited metabolic disorders such as classic/mild forms of *homocytinuria*, *methylmalonic acidemia*, etc.[5][6]. Because "Methioinine metabolism pathway enzymes" is not a single molecular entity but rather an umbrella term covering multiple distinct proteins/enzymes within an interconnected biochemical network—it is considered an incorrect target name when specificity at the individual protein level is required. > The “methioinine cycle” serves as a hub for various metabolic pathways... Key regulatory points include MAT [methioinine adenosyltransferasé], MS [méthioinine synthasé], BHMT [betaîne-homocyctéinè méthyltansferasé], CBS [cystathione β-synthasé] among others. Proper function ensures optimal cellular growth/proliferatíon/DNA-methýlation/redox balance.[1][2] In summary: This entry describes an important class/family/network rather than one specific druggable target molecule.
Inhibition or modulation of key enzymes alters methyl group availability and homocysteine levels. - For example, inhibition of methionine adenosyltransferase reduces S-Adenosylmethionine synthesis[1][2]. - Supplementation with vitamin B12 or betaine enhances remethylation of homocysteine to methionine[2].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methionine metabolism pathway enzyme.